Return to search results.
Complete title: A Phase 1 Study Of PF-05082566 As A Single Agent In Patients With Advanced Cancer, And In Combination With Rituximab In Patients With Non-Hodgkins Lymphoma (NHL)
|Research Study Number||20110654|
|Principal Investigator||Ajay Gopal, MD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Genders Eligible for Study: Both
- Adequate bone marrow, renal, liver and cardiac function
- Exclusion Criteria:
- Autoimmune disorders, CNS malignancies
Other eligibility criteria may apply.
Hematologic Malignancies; Lymphoma; Non-Hodgkin's Lymphoma (NHL)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.